共 161 条
- [1] Olefsky JM(2000)PPAR gamma and the treatment of insulin resistance Trends Endocrinol Metab 11 362-368
- [2] Saltiel AR(2000)Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists J Clin Invest 106 467-472
- [3] Olefsky JM(1999)PPARgamma: an essential regulator of adipogenesis and modulator of fat cell function Cell 99 239-242
- [4] Lowell BB(2001)PPARgamma: a nuclear regulator of metabolism, differentiation, and cell growth J Biol Chem 276 37731-37734
- [5] Rosen ED(2002)Insulin and rosiglitazone regulation of lipolysis and lipogenesis in human adipose tissue in vitro Diabetes 51 1493-1498
- [6] Spiegelman BM(2002)A futile metabolic cycle activated in adipocytes by antidiabetic agents Nat Med 8 1122-1128
- [7] McTernan PG(2004)Effects of rosiglitazone on gene expression in subcutaneous adipose tissue in highly active antiretroviral therapy-associated lipodystrophy Am J Physiol Endocrinol Metab 286 E941-E949
- [8] Harte AL(2004)Brown adipose tissue: function and physiological significance Physiol Rev 84 277-359
- [9] Anderson LA(1996)Activation of the nuclear receptor peroxisome proliferator-activated receptor gamma promotes brown adipocyte differentiation J Biol Chem 271 29909-29914
- [10] Guan HP(1997)3′,5′-cyclic adenosine monophosphate-response sequences of the uncoupling protein gene are sequentially recruited during darglitazone-induced brown adipocyte differentiation Endocrinology 138 5325-5332